CHICAGO -- Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial ...
How finally accepting her diagnosis and being proactive with her health helped one woman manage her lung condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback